Package 68001-132-00

{"route": ["ORAL"], "spl_id": "facbe2e1-8ede-d7e4-e053-6394a90ae44f", "openfda": {"unii": ["864V2Q084H", "N1SN99T69T"], "rxcui": ["898342", "898346", "898350", "898353", "898356", "898359"], "spl_set_id": ["df8e23c8-6c8f-4293-8a37-5ad3d48dba94"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (68001-132-00)", "package_ndc": "68001-132-00", "marketing_start_date": "20150716"}], "brand_name": "Amlodipine Besylate and Benazepril Hydrochloride", "product_id": "68001-132_facbe2e1-8ede-d7e4-e053-6394a90ae44f", "dosage_form": "CAPSULE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "68001-132", "generic_name": "Amlodipine Besylate and Benazepril Hydrochloride", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine Besylate and Benazepril Hydrochloride", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "2.5 mg/1"}, {"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA078466", "marketing_category": "ANDA", "marketing_start_date": "20150716", "listing_expiration_date": "20261231"}